U.S. Health Alert: Salmonella Outbreak Linked to ‘Rosabella’ Moringa Capsules, Antibiotic Resistance a Concern
Consumers in the United States are being warned about a multi-state outbreak of Salmonella Newport infections linked to capsules containing moringa powder sold under the brand name “Rosabella.” The European Rapid Alert System for Food and Feed (RASFF), through the European Food Safety Authority (EFSA), flagged the outbreak, raising concerns about antibiotic resistance in the identified bacterial strain. The Centers for Disease Control and Prevention (CDC) has confirmed seven cases across seven states, with three individuals requiring hospitalization. This situation highlights the growing global challenge of antibiotic-resistant infections and the importance of rigorous food safety standards.
The outbreak isn’t limited to a simple case of foodborne illness; the Salmonella Newport strain isolated from patients demonstrates resistance to multiple antibiotics, including those commonly used as first-line treatments and alternative therapies for salmonellosis. This resistance complicates treatment and increases the risk of severe illness and potential complications. The increasing prevalence of antibiotic-resistant bacteria is a significant public health threat, diminishing the effectiveness of crucial medications and requiring more aggressive and potentially toxic treatment regimens.
Product Recall: 52 Lots of ‘Rosabella Moringa Capsules’ Affected
In response to the outbreak, Ambrosia Brands, LLC, the distributor of “Rosabella Moringa Capsules,” has initiated a voluntary recall of 52 lots of the 60-capsule product. The recalled capsules have expiration dates ranging from March to November 2027. Consumers are urged to check the lot numbers printed on the packaging. All recalled lots start with the number “1356,” followed by a seven-digit lot number and either “1” or “2.” For example, a recalled lot number might appear as “1356-5060080-1.” The U.S. Food and Drug Administration (FDA) published a formal recall notice on February 29, 2024, detailing the affected lots and providing guidance to consumers. FDA Recall Notice
The FDA’s recall notice emphasizes that consumers should not consume the recalled “Rosabella Moringa Capsules” and should refrain from distributing them to others. Proper disposal of the product is also recommended to prevent accidental ingestion. The FDA advises consumers experiencing symptoms of Salmonella infection after consuming the product to seek medical attention immediately.
Where Were These Capsules Sold? Online Platforms Identified
Ambrosia Brands, LLC, has informed consumers that the recalled “Rosabella Moringa Capsules” were sold online through the distributor’s website, tryrosabella.com, as well as through several major online platforms. These platforms include eBay.com, Shein, TikTok Shop, and other online retailers. The widespread availability of the product through multiple online channels increases the potential for exposure and underscores the importance of the recall. The FDA’s recall notice provides a comprehensive list of retailers and links to their respective recall information pages, where available.
The popularity of moringa as a dietary supplement, often marketed for its purported health benefits, has grown in recent years. Moringa is derived from the leaves of the moringa oleifera tree and is rich in vitamins, minerals, and antioxidants. However, the supplement industry is not as heavily regulated as the pharmaceutical industry, which can lead to inconsistencies in product quality and potential contamination risks. Consumers should exercise caution when purchasing dietary supplements and choose brands that adhere to good manufacturing practices and undergo third-party testing.
Understanding Salmonella and the Risks of Antibiotic Resistance
Salmonella is a genus of bacteria that can cause illness in humans, typically through the consumption of contaminated food. Symptoms of Salmonella infection, known as salmonellosis, include diarrhea, fever, and abdominal cramps. Most individuals recover within four to seven days without treatment, but severe cases can require hospitalization. The CDC estimates that Salmonella causes approximately 1.35 million infections, 26,500 hospitalizations, and 420 deaths in the United States each year. CDC Salmonella Information
Antibiotic resistance occurs when bacteria evolve to withstand the effects of antibiotics, rendering these drugs ineffective. This resistance develops through genetic mutations and is accelerated by the overuse and misuse of antibiotics. The World Health Organization (WHO) considers antibiotic resistance one of the top 10 global public health threats facing humanity. The emergence of multi-drug resistant strains of Salmonella, like the one identified in this outbreak, poses a significant challenge to public health efforts to control and treat foodborne illnesses.
RASFF and International Food Safety Collaboration
The Rapid Alert System for Food and Feed (RASFF) is a crucial component of the European Union’s food safety infrastructure. Established in 1998, RASFF facilitates the rapid exchange of information between EU member states and the European Commission regarding serious risks identified in the food chain. The system allows for swift action to be taken to protect consumers, including product recalls, import controls, and public health warnings. The RASFF’s involvement in alerting authorities to the “Rosabella” moringa capsule outbreak demonstrates the importance of international collaboration in addressing food safety threats that transcend national borders. European Commission RASFF
The EFSA plays a vital role in providing scientific advice and risk assessments to support the European Commission’s food safety policies. EFSA’s expertise is essential in evaluating the potential health risks associated with foodborne hazards and informing decisions related to food safety regulations and standards. The agency’s collaboration with the CDC in investigating the “Rosabella” outbreak highlights the importance of sharing data and expertise to address global food safety challenges.
What Should Consumers Do?
If you have purchased “Rosabella Moringa Capsules” with a lot number beginning with “1356,” check the full lot number against the list provided by the FDA. If your lot number is included in the recall, do not consume the product. Dispose of the capsules safely and do not share them with others. If you have experienced symptoms of Salmonella infection, such as diarrhea, fever, and abdominal cramps, after consuming “Rosabella Moringa Capsules,” seek medical attention and inform your healthcare provider about your potential exposure.
Consumers can stay informed about the recall and other food safety alerts by visiting the FDA website and subscribing to email updates. The CDC also provides valuable information about Salmonella and other foodborne illnesses on its website. Staying vigilant and informed is crucial to protecting yourself and your family from foodborne illnesses.
Key Takeaways:
- A multi-state Salmonella Newport outbreak has been linked to “Rosabella Moringa Capsules.”
- The Salmonella strain is resistant to multiple antibiotics, complicating treatment.
- 52 lots of the product have been recalled with expiration dates between March and November 2027.
- Consumers should check lot numbers and avoid consuming recalled capsules.
- The outbreak highlights the importance of food safety and antibiotic stewardship.
The FDA continues to investigate the outbreak and will provide updates as more information becomes available. Consumers are encouraged to report any adverse reactions or suspected foodborne illnesses to the FDA’s MedWatch program. The next update from the CDC regarding this outbreak is expected within the next two weeks, as they continue to monitor reported cases and analyze the source of the contamination. Please share this information with your friends and family to aid raise awareness and protect public health.